Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Clinical trial NCT06396858 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06396858
- Sponsor
- Brazilian Clinical Research Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-08-01
- Enrollment
- 4500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.